News
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA
Moderna’s COVID shot had previously been approved for everyone 12 and older. The narrower approval follows the FDA announcing it was likely to limit access to immunizations among healthy children and adults under 65 this fall—as well as an announcement by Health Secretary Robert F.
The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...
The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...
In a startling pandemic preparedness development, Moderna yesterday announced that the US Department of Health and Human ...
The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...
The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine ...
Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...
The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test and license mRNA-based vaccines to ...
3don MSN
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S.
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback